PMLT18041 / AGCT1531 / AndolinaResearch Question:
Does monitoring patients with germ cell tumors help prevent tumors from recurring?
Basic Study Information
Purpose:Location: University of Rochester
This phase III trial studies how well active surveillance, bleomycin, etoposide, carboplatin
or cisplatin work in treating pediatric and adult patients with germ cell tumors.
Active surveillance may help doctors to monitor subjects with low risk germ cell tumors
after their tumor is removed. Drugs used in chemotherapy, such as bleomycin, carboplatin,
etoposide, and cisplatin, work in different ways to stop the growth of tumor cells,
either by killing the cells, by stopping them from dividing, or by stopping them from
spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy
to use in treating germ cell tumors.
Lead Researcher (Principal Investigator)
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search